Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R
A more gradual rise in blood levels could reduce the sharp peak that triggers GI side effects in sensitive individuals
Together, they target distinct receptor pathways to study GH pulse amplification and IGF-1 axis modulation
This participant was already taking tirzepatide when she enrolled in the trial, but before any stimulation was delivered, giving us a unique opportunity to make foundational observations about how the drug alters brain signals. At first, results were promising: As patient 3s tirzepatide levels reached full dosage, craving-linked NAc activity in her brain went dormant and she had no obsessive thoughts about food
For 3T3-L1 cells, differentiation was initiated upon confluence (day 0) with DMEM containing 0.5 mM isobutylmethylxanthine (IBMX), 1 M dexamethasone, and 10 g/mL insulin